– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients…
The S&P 500 is at an all-time high. However, not all stocks in the widely followed index are setting records.…
I think the stock markets valuation has become frothy. And Im in good company; Warren Buffetts actions show that he…
Ill never get tired of praising dividend stocks as the markets unsung heroes. While they arent as sexy as high-flying…
If youre trying to secure a stream of passive income to support your retirement dreams, theres more than one way…
Urban Outfitters, Maplebear, Pfizer and Alcoa have been highlighted in this Screen of The Week article.…
Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports…
…
Things arent getting much better for Pfizer (NYSE: PFE). The company is still suffering from the significant drop in sales…
Investing $5,000 can be a good amount to put into a growth stock because it can lead to significant long-term…
Investors with a long-term horizon may consider buying PFE stock at its present attractive valuation.…
Top-ranked stocks Urban Outfitters, Maplebear, Pfizer and Alcoa are likely to beat on the bottom line in their upcoming releases.…
It is hard to get excited after looking at Pfizers (NYSE:PFE) recent performance, when its stock has declined 10.0...…
…
Theres a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers…
The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1%…
…
You dont have to be an income investor to like dividends. Many billionaires who definitely dont need income still have…
Despite Pfizers (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its leadership,…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 27 auf 29 US-Dollar angehoben, aber die…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 27 auf 29 US-Dollar angehoben, aber die…
Every so often in an investors life, there will be a stock that you really want to own, but that…
Its Black Friday, the biggest shopping day of the year. Shoppers across the country are elbowing their way through the…
One stock that just cant seem to catch a break of late is Pfizer (NYSE: PFE). Even though it posted…
…
Nobody can predict the future, but its not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in…
The power of owning dividend-paying stocks is often underappreciated. Consider, for example, that a study by Hartford Funds and Ned…
Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical…
NEW HAVEN, Conn., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters…
On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. This…
Die Pfizer-Aktie verzeichnete am 23. November einen minimalen Kursanstieg von 0,04 Prozent auf 24,58 Euro im Vergleich zum Vortag. Diese…
…
…
…
Every company faces challenges. Sometimes, those issues are deeply damaging to a corporations investment thesis. Other times, though, thats not…
Collecting an above-average dividend payment can sometimes come with risks. High-yielding stocks can be due for cuts to their payouts…
Große Pharma-Unternehmen stehen in der Regel für einen defensiven Investmentcharakter. Mit einem relativ unbekannten europäischen Player, der inzwischen gut 30…
Große Pharma-Unternehmen stehen in der Regel für einen defensiven Investmentcharakter. Mit einem relativ unbekannten europäischen Player, der inzwischen gut 30…
Pfizer said it has named Chris Boshoff, who led the drugmakers cancer research and marketing for more than a year,…
Pfizer names insider Chris Boshoff as R&D chief…
Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY)…
…
Pfizer loses bid to recoup $75 million left over from SEC settlement…
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. Heres why these two high-yield dividend…
Hims & Hers Health strengthens clinical excellence with two strategic appointments: former FDA deputy commissioner Deb Autor joins board, while…
Rund zwei Monate vor dem Amtsantritt von Donald Trump nimmt dessen Kabinett langsam Formen an. Die Presse findet für die…
STORY: U.S. stocks slumped on Friday after Federal Reserve Chair Jerome Powell signaled a slower pace of interest-rate cuts and…
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Todays…
Heres a look at Pfizer, Applied Materials, Bloom Energy, Palantir and FuelCell Energy. Fridays Top 5 Trending Stocks.…